From a chemical therapeutics standpoint, Relafen 750 (Naproxen ) presents a fascinating case study in medication action. Its mechanism of action primarily involves the suppression of cyclooxygenase ( COX mediators) enzymes, particularly COX-II , leading to a decrease in the synthesis of prostaglandins . This selective inhibition accounts for its pa